American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Norton
    Norton
  8. Schultz
    Schultz
  9. Weigelt
    Weigelt
  10. Chandarlapaty
    Chandarlapaty

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of FHD-609, a heterobifunctional degrader of bromodomain-containing protein 9, in patients with advanced synovial sarcoma or SMARCB1-deficient tumors
    Journal Article

    Livingston, J. A.; Blay, J. Y.; Trent, J.; Valverde, C.; Agulnik, M.; Gounder, M.; Le Cesne, A.; McKean, M.; Wagner, M. J.; Stacchiotti, S.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • The prostaglandin EP4 antagonist vorbipiprant combined with PD-1 blockade for refractory microsatellite-stable metastatic colorectal cancer: A phase Ib/IIa trial
    Journal Article

    Pietrantonio, F.; Morano, F.; Niger, M.; Ghelardi, F.; Chiodoni, C.; Palazzo, M.; Nichetti, F.; Manca, P.; Cristarella, E.; Doldi, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions
    Journal Article

    Lamoureux, A. A.; Fisher, M. J.; Lemelle, L.; Pfaff, E.; Amir-Yazdani, P.; Kramm, C.; De Wilde, B.; Kazanowska, B.; Hutter, C.; Pfister, S. M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Framework for the pathology workup of metastatic castration-resistant prostate cancer biopsies
    Journal Article

    Haffner, M. C.; Morris, M. J.; Ding, C. K. C.; Sayar, E.; Mehra, R.; Robinson, B.; True, L. D.; Gleave, M.; Lotan, T. L.; Aggarwal, R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Safety and tolerability of letetresgene autoleucel (GSK3377794): Pilot studies in patients with advanced non–small cell lung cancer
    Journal Article

    Altan, M.; Lopes, G.; Hiltermann, T. N. J.; Govindan, R.; Villaruz, L. C.; Calvo, E.; Edelman, M. J.; Furqan, M.; Neal, J.; Felip, E.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Analysis of shared variants between cancer biospecimens
    Journal Article

    Foote, M. B.; White, J. R.; Chatila, W. K.; Argilés, G.; Lu, S.; Rousseau, B.; Artz, O.; Johannet, P.; Walch, H.; Patel, M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A first-in-human study of cinrebafusp alfa, a HER2/4-1BB bispecific molecule, in patients with HER2-positive advanced solid malignancies
    Journal Article

    Piha-Paul, S.; Olwill, S. A.; Hamilton, E.; Tolcher, A.; Pohlmann, P.; Liu, S. V.; Wurzenberger, C.; Hasenkamp, L. C.; Hansbauer, E. M.; Shroff, R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Divergent clinical and immunologic outcomes based on STK11 Co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade
    Journal Article

    Rosner, S.; Connor, S.; Sanber, K.; Zahurak, M.; Zhang, T.; Gurumurthy, I.; Zeng, Z.; Presson, B.; Singh, D.; Rayes, R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Phase II study of palbociclib in patients with tumors with CDK4 or CDK6 amplification: Results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol Z1C
    Journal Article

    O’Hara, M. H.; Jegede, O.; Dickson, M. A.; DeMichele, A. M.; Piekarz, R.; Gray, R. J.; Wang, V.; McShane, L. M.; Rubinstein, L. V.; Patton, D. R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase II study of acimtamig (AFM13) in patients with CD30-positive, relapsed, or refractory peripheral T-cell lymphomas
    Journal Article

    Kim, W. S.; Shortt, J.; Zinzani, P. L.; Mikhailova, N.; Radeski, D.; Ribrag, V.; Domenech, E. D.; Sawas, A.; Alexis, K.; Emig, M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: